Silica for 3D Printing: Uses in Resins, Powders and Binder Jetting

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Fused Silica Sand? Properties and Uses in Investment Casting and Refractories
  • Keywords: white carbon black
  • Published: 2026-11-20 06:17:55
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Silica Stocks: Publicly Listed Silica and Quartz Companies to Know

HDK N20: Specifications, Applications and Equivalent Grades
49. Dwyer L.M., Michaelis V.K., O'Mahony M., Griffin R.G., Myerson A.S. Confined crystallization of fenofibrate in nanoporous silica. CrystEngComm. 2015;17:7922-7929. doi: 10.1039/C5CE01148E. [ DOI ] [ PMC free post ] [ PubMed ] [ Google Scholar ]
Silica Price Trend 2026: Historical Prices and Market Drivers
Although the advent of active and passive targeting, particularly stimulus-responsive gates, represents a perfect marriage of the latest advancement and actual usage, e.g., folic acid and pH-responsive systems, a reference to likely challenges involved would be appropriate.
Silica 99% Purity: Specifications, Grades and Typical Applications
Silica Supplier UAE: How to Source Silica for the UAE and GCC Markets
One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].

Silicon Dioxide Structure: Tetrahedral Network and Crystal Forms Explained

What is silica (SiO₂)?

quartz powder for ceramics

What is the difference between fumed silica and precipitated silica?

hydrated silica

What drives silica raw material prices?

amorphous vs crystalline silica 33. Zhang J., Dong Y., Liu X., Jin H., Wang S., An N., Wang L. Effective myocardial infarction treatment by targeted accumulation of Sulforaphane using porous magnetic silica nanoparticles. Int. J. Pharm. 2023;645:123389. doi: 10.1016/j.ijpharm.2023.123389. [ DOI ] [ PubMed ] [ Google Scholar ]

Cite this article: Silica Raw Materials News. "Silica for Electronic Encapsulation: Purity, CTE and Particle Size Requirements ." Published 2026-11-20 06:17:55. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.